Global and Europe Capecitabine Market Professional Survey Report 2019

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

    The Global Capecitabine market was valued at XX.0 million US$ in 2018, with the CAGR of 1.9%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Capecitabine market. Describe product range of Capecitabine, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Capecitabine market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Capecitabine market.

     

    By Player

    • Teva

    • Hikma

    • Cipla

    • Hetero

    • Reliance Group

    • Mylan

    • Hengrui Medicine

    • Roche

    By Type

    • 500 mg

    • 150 mg

    By End-User

    • Breast Cancer

    • Colorectal cancer

    • Stomach Cancer

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Capecitabine Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Capecitabine Market Size and Growth Rate of 500 mg from 2014 to 2026

      • 1.3.2 Global Capecitabine Market Size and Growth Rate of 150 mg from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Capecitabine Market Size and Growth Rate of Breast Cancer from 2014 to 2026

      • 1.4.2 Global Capecitabine Market Size and Growth Rate of Colorectal cancer from 2014 to 2026

      • 1.4.3 Global Capecitabine Market Size and Growth Rate of Stomach Cancer from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Capecitabine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Capecitabine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Capecitabine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Capecitabine Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Capecitabine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Capecitabine by Major Types

      • 3.4.1 Capecitabine Market Size and Growth Rate of 500 mg

      • 3.4.2 Capecitabine Market Size and Growth Rate of 150 mg

    4 Segmentation of Capecitabine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Capecitabine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Capecitabine for Breast Cancer

      • 4.4.2 Market Size and Growth Rate of Capecitabine for Colorectal cancer

      • 4.4.3 Market Size and Growth Rate of Capecitabine for Stomach Cancer

    5 Market Analysis by Major Regions

    • 5.1 Global Capecitabine Production Analysis by Top Regions

    • 5.2 Global Capecitabine Consumption Analysis by Top Regions

    • 5.3 Global Capecitabine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Capecitabine Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Capecitabine Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Capecitabine Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Capecitabine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Capecitabine Market among Top Countries

    • 6.1 Top 5 Export Countries in Capecitabine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Capecitabine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Capecitabine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Capecitabine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Capecitabine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Capecitabine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Capecitabine Landscape Analysis

    • 7.1 North America Capecitabine Landscape Analysis by Top Countries

      • 7.1.1 United States Capecitabine Market Volume and Growth Rate

      • 7.1.2 Canada Capecitabine Market Volume and Growth Rate

      • 7.1.3 Mexico Capecitabine Market Volume and Growth Rate

    8. Europe Capecitabine Landscape Analysis

    • 8.1 Europe Capecitabine Landscape Analysis by Major Types

    • 8.2 Europe Capecitabine Landscape Analysis by Major End-Users

    • 8.3 Europe Capecitabine Landscape Analysis by Top Countries

      • 8.3.1 Germany Capecitabine Market Volume and Growth Rate

      • 8.3.2 UK Capecitabine Market Volume and Growth Rate

      • 8.3.3 France Capecitabine Market Volume and Growth Rate

      • 8.3.4 Italy Capecitabine Market Volume and Growth Rate

      • 8.3.5 Spain Capecitabine Market Volume and Growth Rate

      • 8.3.6 Belgium Capecitabine Market Volume and Growth Rate

      • 8.3.7 Poland Capecitabine Market Volume and Growth Rate

      • 8.3.8 Russia Capecitabine Market Volume and Growth Rate

      • 8.3.9 Turkey Capecitabine Market Volume and Growth Rate

      • 8.3.10 Netherlands Capecitabine Market Volume and Growth Rate

      • 8.3.11 Portugal Capecitabine Market Volume and Growth Rate

      • 8.3.12 Denmark Capecitabine Market Volume and Growth Rate

      • 8.3.13 Finland Capecitabine Market Volume and Growth Rate

      • 8.3.14 Iceland Capecitabine Market Volume and Growth Rate

      • 8.3.15 Norway Capecitabine Market Volume and Growth Rate

      • 8.3.16 Sweden Capecitabine Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Capecitabine Landscape Analysis

    • 9.1 Asia Pacific Capecitabine Landscape Analysis by Top Countries

      • 9.1.1 China Capecitabine Market Volume and Growth Rate

      • 9.1.2 Japan Capecitabine Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Capecitabine Market Volume and Growth Rate

      • 9.1.4 India Capecitabine Market Volume and Growth Rate

      • 9.1.5 ASEAN Capecitabine Market Volume and Growth Rate

      • 9.1.6 South Korea Capecitabine Market Volume and Growth Rate

    10 LAMEA Capecitabine Landscape Analysis

    • 10.1 LAMEA Capecitabine Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Capecitabine Market Volume and Growth Rate

      • 10.1.2 Brazil Capecitabine Market Volume and Growth Rate

      • 10.1.3 North Africa Capecitabine Market Volume and Growth Rate

      • 10.1.4 South Africa Capecitabine Market Volume and Growth Rate

      • 10.1.5 Argentina Capecitabine Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Teva

      • 11.1.1 Teva Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Hikma

      • 11.2.1 Hikma Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Cipla

      • 11.3.1 Cipla Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Hetero

      • 11.4.1 Hetero Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Reliance Group

      • 11.5.1 Reliance Group Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Mylan

      • 11.6.1 Mylan Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Hengrui Medicine

      • 11.7.1 Hengrui Medicine Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Roche

      • 11.8.1 Roche Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 110 Figures and 185 Tables)

    • Figure Product Picture

    • Figure Capecitabine Market Size and Growth Rate of 500 mg from 2014 to 2026

    • Figure Capecitabine Market Size and Growth Rate of 150 mg from 2014 to 2026

    • Figure Global Capecitabine Market Size and Growth Rate of Breast Cancer from 2014 to 2026

    • Figure Global Capecitabine Market Size and Growth Rate of Colorectal cancer from 2014 to 2026

    • Figure Global Capecitabine Market Size and Growth Rate of Stomach Cancer from 2014 to 2026

    • Figure North America Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure United States Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure France Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure China Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure India Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Capecitabine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Capecitabine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Capecitabine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Capecitabine by Different Types from 2014 to 2026

    • Table Consumption Share of Capecitabine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of 500 mg

    • Figure Market Size and Growth Rate of 150 mg

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Capecitabine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Capecitabine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Colorectal cancer

    • Figure Market Size and Growth Rate of Stomach Cancer

    • Table Global Capecitabine Production by Major Regions

    • Table Global Capecitabine Production Share by Major Regions

    • Table Global Capecitabine Consumption by Major Regions

    • Table Global Capecitabine Consumption Share by Major Regions

    • Table North America Capecitabine Production, Import, Consumption and Export Analysis

    • Table Europe Capecitabine Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Capecitabine Production, Import, Consumption and Export Analysis

    • Table LAMEA Capecitabine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Capecitabine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Capecitabine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Capecitabine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Capecitabine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Capecitabine Consumption by Major Countries from 2014 to 2026

    • Table North America Capecitabine Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Capecitabine Consumption Share by Major Countries in 2014

    • Figure North America Capecitabine Consumption Share by Major Countries in 2018

    • Figure North America Capecitabine Consumption Share by Major Countries in 2026

    • Figure United States Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Capecitabine Consumption by Types from 2014 to 2026

    • Table Europe Capecitabine Consumption Share by Types from 2014 to 2026

    • Table Europe Capecitabine Consumption by End-Users from 2014 to 2026

    • Table Europe Capecitabine Consumption Share by End-Users from 2014 to 2026

    • Table Europe Capecitabine Consumption by Major Countries from 2014 to 2026

    • Table Europe Capecitabine Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure France Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Capecitabine Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Capecitabine Consumption Share by Major Countries from 2014 to 2026

    • Figure China Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure India Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Capecitabine Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Capecitabine Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Capecitabine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Hikma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hikma

    • Figure Sales and Growth Rate Analysis of Hikma

    • Figure Revenue and Market Share Analysis of Hikma

    • Table Product and Service Introduction of Hikma

    • Table Company Profile and Development Status of Cipla

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla

    • Figure Sales and Growth Rate Analysis of Cipla

    • Figure Revenue and Market Share Analysis of Cipla

    • Table Product and Service Introduction of Cipla

    • Table Company Profile and Development Status of Hetero

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hetero

    • Figure Sales and Growth Rate Analysis of Hetero

    • Figure Revenue and Market Share Analysis of Hetero

    • Table Product and Service Introduction of Hetero

    • Table Company Profile and Development Status of Reliance Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Reliance Group

    • Figure Sales and Growth Rate Analysis of Reliance Group

    • Figure Revenue and Market Share Analysis of Reliance Group

    • Table Product and Service Introduction of Reliance Group

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Hengrui Medicine

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hengrui Medicine

    • Figure Sales and Growth Rate Analysis of Hengrui Medicine

    • Figure Revenue and Market Share Analysis of Hengrui Medicine

    • Table Product and Service Introduction of Hengrui Medicine

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.